SCHEMBL7136372

SCHEMBL7136372

O=C1Nc2ccc(CCCl)cc2C1=Cc1ccc(O)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 4/20 0.49
PSEN1 P49768 3/20 0.49
PSEN2 P49810 3/20 0.49
APH1B Q8WW43 3/20 0.49
NCSTN Q92542 3/20 0.49
APH1A Q96BI3 3/20 0.49
PSENEN Q9NZ42 3/20 0.49
PDPK1 O15530 6/20 0.46
KDR P35968 2/20 0.46
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
FLT1 P17948 1/20 0.46
APP P05067 1/20 0.44
MAPT P10636 1/20 0.44
SNCA P37840 1/20 0.44
PLK4 O00444 1/20 0.42
PLK1 P53350 1/20 0.42
RAF1 P04049 1/20 0.42
NTRK1 P04629 1/20 0.41
MDM2 Q00987 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7135626 0.88 MDM2 (0.50) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5366450 0.86 FLT3 (0.50) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5364261 0.85 MDM2 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7139603 0.85 MEN1 (0.49) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5361064 0.83 RAF1 (0.46) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7135240 0.82 KDR (0.44) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5367186 0.82 LRRK2 (0.53) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7133928 0.81 LRRK2 (0.53) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7136250 0.81 RAF1 (0.56) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5373291 0.81 MDM2 (0.55) LRRK2PDPK1KDRPDGFRBFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed